Financials data is unavailable for this security.
View more
Year on year Fresenius Medical Care AG 's net income fell -25.90% from 673.41m to 499.00m despite relatively flat revenues.
Gross margin | 25.32% |
---|---|
Net profit margin | 3.77% |
Operating margin | 7.04% |
Return on assets | 2.10% |
---|---|
Return on equity | 3.61% |
Return on investment | 2.69% |
More ▼
Cash flow in EURView more
In 2023, Fresenius Medical Care AG increased its cash reserves by 12.05%, or 153.44m. The company earned 2.63bn from its operations for a Cash Flow Margin of 13.51%. In addition the company used 544.23m on investing activities and also paid 1.86bn in financing cash flows.
Cash flow per share | 8.18 |
---|---|
Price/Cash flow per share | 4.62 |
Book value per share | 46.42 |
---|---|
Tangible book value per share | -8.15 |
More ▼
Balance sheet in EURView more
Current ratio | 1.42 |
---|---|
Quick ratio | 1.07 |
Total debt/total equity | 0.8847 |
---|---|
Total debt/total capital | 0.4484 |
More ▼
Growth rates in EUR
Year on year, growth in dividends per share increased 6.25% while earnings per share excluding extraordinary items fell by -25.94%. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 2.59% |
---|---|
Div growth rate (5 year) | 0.34% |
Payout ratio (TTM) | 69.94% |
EPS growth(5 years) | -23.40 |
---|---|
EPS (TTM) vs TTM 1 year ago | -25.94 |
More ▼